Medical - Instruments & Supplies
Compare Stocks
5 / 10Stock Comparison
DXR vs TFX vs HOLX vs BDX vs BAX
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
Medical - Instruments & Supplies
Medical - Instruments & Supplies
Medical - Instruments & Supplies
DXR vs TFX vs HOLX vs BDX vs BAX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies | Medical - Instruments & Supplies | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $56M | $5.83B | $16.97B | $55.53B | $9.04B |
| Revenue (TTM) | $868K | $2.81B | $4.13B | $21.36B | $11.32B |
| Net Income (TTM) | $3M | $-1.01B | $544M | $1.14B | $-1.10B |
| Gross Margin | 91.4% | 53.3% | 52.8% | 46.5% | 30.1% |
| Operating Margin | 5.4% | 5.6% | 17.5% | 10.6% | -2.7% |
| Forward P/E | 87.8x | 19.6x | 17.2x | 12.3x | 9.2x |
| Total Debt | $730K | $2.73B | $2.63B | $19.18B | $10.00B |
| Cash & Equiv. | — | $393M | $1.96B | $851M | $1.97B |
DXR vs TFX vs HOLX vs BDX vs BAX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Daxor Corporation (DXR) | 100 | 72.5 | -27.5% |
| Teleflex Incorporat… (TFX) | 100 | 36.3 | -63.7% |
| Hologic, Inc. (HOLX) | 100 | 142.6 | +42.6% |
| Becton, Dickinson a… (BDX) | 100 | 103.0 | +3.0% |
| Baxter Internationa… (BAX) | 100 | 19.5 | -80.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DXR vs TFX vs HOLX vs BDX vs BAX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DXR carries the broadest edge in this set and is the clearest fit for quality and stability.
- 401.5% margin vs TFX's -35.9%
- Beta 0.33 vs BAX's 1.37, lower leverage
- 9.8% ROA vs TFX's -13.9%, ROIC 1.3% vs 3.4%
TFX lags the leaders in this set but could rank higher in a more targeted comparison.
HOLX is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 124.3% 10Y total return vs BDX's 80.2%
- Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
- Beta 0.41, current ratio 3.75x
BDX is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 1 yrs, beta 0.66, yield 2.7%
- Rev growth 8.2%, EPS growth -0.5%, 3Y rev CAGR 5.0%
- 8.2% revenue growth vs DXR's -93.8%
- 2.7% yield, 1-year raise streak, vs BAX's 3.9%, (2 stocks pay no dividend)
BAX ranks third and is worth considering specifically for value.
- Lower P/E (9.2x vs 12.3x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.2% revenue growth vs DXR's -93.8% | |
| Value | Lower P/E (9.2x vs 12.3x) | |
| Quality / Margins | 401.5% margin vs TFX's -35.9% | |
| Stability / Safety | Beta 0.33 vs BAX's 1.37, lower leverage | |
| Dividends | 2.7% yield, 1-year raise streak, vs BAX's 3.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +51.8% vs BAX's -41.8% | |
| Efficiency (ROA) | 9.8% ROA vs TFX's -13.9%, ROIC 1.3% vs 3.4% |
DXR vs TFX vs HOLX vs BDX vs BAX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DXR vs TFX vs HOLX vs BDX vs BAX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DXR leads in 1 of 6 categories
BAX leads 1 • HOLX leads 1 • BDX leads 1 • TFX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DXR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BDX is the larger business by revenue, generating $21.4B annually — 24618.1x DXR's $867,859. DXR is the more profitable business, keeping 4.0% of every revenue dollar as net income compared to TFX's -35.9%. On growth, BAX holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $867,859 | $2.8B | $4.1B | $21.4B | $11.3B |
| EBITDAEarnings before interest/tax | $7M | $280M | $974M | $4.2B | $671M |
| Net IncomeAfter-tax profit | $3M | -$1.0B | $544M | $1.1B | -$1.1B |
| Free Cash FlowCash after capex | -$5M | $249M | $1000M | $3.1B | $501M |
| Gross MarginGross profit ÷ Revenue | +91.4% | +53.3% | +52.8% | +46.5% | +30.1% |
| Operating MarginEBIT ÷ Revenue | +5.4% | +5.6% | +17.5% | +10.6% | -2.7% |
| Net MarginNet income ÷ Revenue | +4.0% | -35.9% | +13.2% | +5.3% | -9.7% |
| FCF MarginFCF ÷ Revenue | -5.4% | +8.9% | +24.2% | +14.7% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -74.4% | -21.8% | +2.5% | -10.6% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +78.2% | -108.7% | -9.2% | -2.0% | -112.0% |
Valuation Metrics
BAX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 26.3x trailing earnings, BDX trades at a 70% valuation discount to DXR's 87.8x P/E. On an enterprise value basis, BDX's 14.7x EV/EBITDA is more attractive than DXR's 27.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $56M | $5.8B | $17.0B | $55.5B | $9.0B |
| Enterprise ValueMkt cap + debt − cash | $57M | $8.2B | $17.6B | $73.9B | $17.1B |
| Trailing P/EPrice ÷ TTM EPS | 87.82x | -6.50x | 30.53x | 26.29x | -10.01x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 19.59x | 17.21x | 12.27x | 9.17x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.59x | — |
| EV / EBITDAEnterprise value multiple | 27.70x | 18.82x | 17.39x | 14.65x | 25.37x |
| Price / SalesMarket cap ÷ Revenue | 26.42x | 2.93x | 4.14x | 2.54x | 0.80x |
| Price / BookPrice ÷ Book value/share | 1.31x | 1.88x | 3.43x | 1.73x | 1.47x |
| Price / FCFMarket cap ÷ FCF | 2190.99x | 23.75x | 18.44x | 20.80x | 27.99x |
Profitability & Efficiency
HOLX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-28 for TFX. DXR carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to BAX's 1.64x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs BAX's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.1% | -28.3% | +11.0% | +4.5% | -16.5% |
| ROA (TTM)Return on assets | +9.8% | -13.9% | +6.1% | +2.1% | -5.4% |
| ROICReturn on invested capital | +1.3% | +3.4% | +9.4% | +4.3% | -1.4% |
| ROCEReturn on capital employed | +1.7% | +4.0% | +8.8% | +5.4% | -1.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.02x | 0.87x | 0.52x | 0.76x | 1.64x |
| Net DebtTotal debt minus cash | $729,966 | $2.3B | $667M | $18.3B | $8.0B |
| Cash & Equiv.Liquid assets | — | $393M | $2.0B | $851M | $2.0B |
| Total DebtShort + long-term debt | $729,966 | $2.7B | $2.6B | $19.2B | $10.0B |
| Interest CoverageEBIT ÷ Interest expense | -6.11x | -2.02x | 8.00x | 4.09x | -0.83x |
Total Returns (Dividends Reinvested)
BDX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BDX five years ago would be worth $11,693 today (with dividends reinvested), compared to $2,566 for BAX. Over the past 12 months, BDX leads with a +51.8% total return vs BAX's -41.8%. The 3-year compound annual growth rate (CAGR) favors BDX at 1.6% vs BAX's -24.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -32.7% | +7.9% | +1.9% | +0.7% | -10.2% |
| 1-Year ReturnPast 12 months | +29.3% | +9.0% | +37.1% | +51.8% | -41.8% |
| 3-Year ReturnCumulative with dividends | -17.8% | -47.6% | -8.5% | +5.0% | -56.3% |
| 5-Year ReturnCumulative with dividends | +3.3% | -66.4% | +15.8% | +16.9% | -74.3% |
| 10-Year ReturnCumulative with dividends | +21.9% | -10.3% | +124.3% | +80.2% | -42.4% |
| CAGR (3Y)Annualised 3-year return | -6.3% | -19.4% | -2.9% | +1.6% | -24.1% |
Risk & Volatility
Evenly matched — DXR and HOLX each lead in 1 of 2 comparable metrics.
Risk & Volatility
DXR is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than BAX's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs BAX's 53.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 1.06x | 0.41x | 0.66x | 1.37x |
| 52-Week HighHighest price in past year | $14.76 | $139.63 | $76.04 | $205.52 | $32.68 |
| 52-Week LowLowest price in past year | $7.13 | $100.18 | $52.81 | $100.31 | $15.73 |
| % of 52W HighCurrent price vs 52-week peak | +65.4% | +94.3% | +100.0% | +74.6% | +53.6% |
| RSI (14)Momentum oscillator 0–100 | 48.0 | 48.5 | 69.1 | 32.2 | 44.0 |
| Avg Volume (50D)Average daily shares traded | 11K | 884K | 10.0M | 2.5M | 8.7M |
Analyst Outlook
Evenly matched — BDX and BAX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TFX as "Buy", HOLX as "Hold", BDX as "Buy", BAX as "Hold". Consensus price targets imply 12.8% upside for BAX (target: $20) vs 0.4% for TFX (target: $132). For income investors, BAX offers the higher dividend yield at 3.87% vs TFX's 1.02%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $132.20 | $79.00 | $172.85 | $19.75 |
| # AnalystsCovering analysts | — | 29 | 42 | 33 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | +1.0% | — | +2.7% | +3.9% |
| Dividend StreakConsecutive years of raises | 0 | 0 | — | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $1.35 | — | $4.17 | $0.68 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.1% | +4.4% | +1.8% | 0.0% |
DXR leads in 1 of 6 categories (Income & Cash Flow). BAX leads in 1 (Valuation Metrics). 2 tied.
DXR vs TFX vs HOLX vs BDX vs BAX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DXR or TFX or HOLX or BDX or BAX a better buy right now?
For growth investors, Becton, Dickinson and Company (BDX) is the stronger pick with 8.
2% revenue growth year-over-year, versus -93. 8% for Daxor Corporation (DXR). Becton, Dickinson and Company (BDX) offers the better valuation at 26. 3x trailing P/E (12. 3x forward), making it the more compelling value choice. Analysts rate Teleflex Incorporated (TFX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DXR or TFX or HOLX or BDX or BAX?
On trailing P/E, Becton, Dickinson and Company (BDX) is the cheapest at 26.
3x versus Daxor Corporation at 87. 8x. On forward P/E, Baxter International Inc. is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — DXR or TFX or HOLX or BDX or BAX?
Over the past 5 years, Becton, Dickinson and Company (BDX) delivered a total return of +16.
9%, compared to -74. 3% for Baxter International Inc. (BAX). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus BAX's -42. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DXR or TFX or HOLX or BDX or BAX?
By beta (market sensitivity over 5 years), Daxor Corporation (DXR) is the lower-risk stock at 0.
33β versus Baxter International Inc. 's 1. 37β — meaning BAX is approximately 317% more volatile than DXR relative to the S&P 500. On balance sheet safety, Daxor Corporation (DXR) carries a lower debt/equity ratio of 2% versus 164% for Baxter International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DXR or TFX or HOLX or BDX or BAX?
By revenue growth (latest reported year), Becton, Dickinson and Company (BDX) is pulling ahead at 8.
2% versus -93. 8% for Daxor Corporation (DXR). On earnings-per-share growth, the picture is similar: Daxor Corporation grew EPS 81. 5% year-over-year, compared to -1468. 2% for Teleflex Incorporated. Over a 3-year CAGR, BDX leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DXR or TFX or HOLX or BDX or BAX?
Daxor Corporation (DXR) is the more profitable company, earning 25.
2% net margin versus -45. 4% for Teleflex Incorporated — meaning it keeps 25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DXR leads at 29. 2% versus -2. 7% for BAX. At the gross margin level — before operating expenses — DXR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DXR or TFX or HOLX or BDX or BAX more undervalued right now?
On forward earnings alone, Baxter International Inc.
(BAX) trades at 9. 2x forward P/E versus 19. 6x for Teleflex Incorporated — 10. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAX: 12. 8% to $19. 75.
08Which pays a better dividend — DXR or TFX or HOLX or BDX or BAX?
In this comparison, BAX (3.
9% yield), BDX (2. 7% yield), TFX (1. 0% yield) pay a dividend. DXR, HOLX do not pay a meaningful dividend and should not be held primarily for income.
09Is DXR or TFX or HOLX or BDX or BAX better for a retirement portfolio?
For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
66), 2. 7% yield). Both have compounded well over 10 years (BDX: +80. 2%, BAX: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DXR and TFX and HOLX and BDX and BAX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DXR is a small-cap quality compounder stock; TFX is a small-cap quality compounder stock; HOLX is a mid-cap quality compounder stock; BDX is a mid-cap quality compounder stock; BAX is a small-cap income-oriented stock. TFX, BDX, BAX pay a dividend while DXR, HOLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.